By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Certain Drugs Can Trigger or Slow Alzheimer’s Disease
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Specialties > Certain Drugs Can Trigger or Slow Alzheimer’s Disease
Specialties

Certain Drugs Can Trigger or Slow Alzheimer’s Disease

Anthony Cirillo
Anthony Cirillo
Share
2 Min Read
alzheimer's drugs
SHARE
alzheimer's drugs
alzheimer's drugs
Good or Bad? Hmmm.

Certain widely prescribed medications can trigger or slow the progress of Alzheimer’s disease, according to recently published research.

A Mount Sinai Medical Center team screened 1,600 FDA-approved medications, using a computer algorithm to determine which drugs are associated with blocking or stimulating beta amyloid accumulation. Amyloid plaques build up in the brains of Alzheimer’s patients.
 
Of the screened drugs, 800 reduced amyloid beta content more than 10% in primary neurons from mice, the researchers found. About 240 drugs promoted amyloid beta.

While many classes of drugs were found to impact amyloid beta production, the researchers focused especially on those used to treat cardiovascular conditions. Certain blood pressure medications, such as propranolol (Inderal) and nicardipine (Cardene), reduced amyloid beta production, while drugs including furosemide (Lasix) had the opposite effect. Experiments with mice confirmed that some CV medications, particularly carvedilol (Coreg), hold promise as Alzheimer’s drugs.
 
“This line of investigation will lead to the identification of common medications that are potentially beneficial or detrimental to [Alzheimer’s disease] as a reference for physicians to consider when prescribing the most appropriate drugs for their patients, particularly for treating chronic disorders among the growing geriatric population,” the researchers wrote.

Source: McKnight’s LTC

More Read

Differentiating Between Myths And The Truth About Nootropics
Custom Lens Replacement: A Modern Vision Solution
Checklist to Keep in Mind Before Starting New Dental Practice
Obesity Burns Gas
What’s the Cause of Chronic Abdominal Pain?
TAGGED:Alzheimer's Disease
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025
Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025

You Might also Like

sealants-global-market
Medical DevicesMedical InnovationsSpecialtiesTechnology

Advanced Wound Closure’s New Players

February 28, 2013
SkinSpecialties

Which Skincare Products Actually Make a Difference?

December 3, 2020
Dental healthSpecialties

Advantages Of Taking A Data-Driven Approach To Run Your Dental Practice

March 17, 2020

AHCA Announces Nursing Home Quality Winners

October 29, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?